Novel gastric mucosal findings in association with proton pump inhibitors

Digestive Endoscopy

Volumn 29, Issue 3, 2017, Pages 294-296

  Isomoto, Hajime ^a   Kurumi, Hiroki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; CHOLECYSTOKININ B RECEPTOR; CYTOCHROME P450 2C19; HORMONE; MESSENGER RNA; PEPSINOGEN; POTASSIUM CHANNEL KCNQ1; PROTON PUMP INHIBITOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; TUMOR NECROSIS FACTOR INHIBITOR; VONOPRAZAN; ANTIULCER AGENT;

BIOPSY; CROHN DISEASE; DIGESTIVE SYSTEM INJURY; DIGESTIVE TRACT ENDOSCOPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EDITORIAL; ESOPHAGOGASTRODUODENOSCOPY; FRACTURE; GASTRIC COBBLESTONE LIKE MUCOSA; GASTRIC CRACKED MUCOSA; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; INTESTINE INFECTION; INTESTINE POLYP; JAPAN; LONG TERM CARE; MORPHOLOGY; OXYNTIC GLAND DILATATION; PARIETAL CELL PROTRUSION; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH ACID SECRETION; STOMACH DISEASE; STOMACH DISTENSION; STOMACH FUNDUS GLAND; STOMACH JUICE; STOMACH MUCOSA INJURY; STOMACH PARIETAL CELL; STOMACH MUCOSA;

ANTI-ULCER AGENTS; GASTRIC MUCOSA; HUMANS; PROTON PUMP INHIBITORS;

EID: 85019120895     PISSN: 09155635     EISSN: 14431661     Source Type: Journal    
DOI: 10.1111/den.12846     Document Type: Editorial

References (10)

1. Kumar KR, Iqbal R, Coss E, Park C, Cryer B, Genta RM. Helicobacter gastritis induces changes in the oxyntic mucosa indistinguishable from the effects of proton pump inhibitors. Hum. Pathol. 2013; 44: 2706–10.
2. Hongo M, Fujimoto K; Gastric Polyps Study Group. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. J. Gastroenterol. 2010; 45: 618–24.
3. Miyamoto S, Kato M, Tsuda M et al. Gastric mucosal cracked and cobblestone-like changes resulting from proton pump inhibitor use. Dig. Endosc. Published online: Dec 2016; DOI:10.1111/den.12765.
4. Kamada T. Endoscopic findings of gastritis. In: Haruma K (ed.). Kyoto Classification of Gastritis. Tokyo: Japan Medical Center, 2016; 91–5.
5. Matsuzaki J, Suzuki H, Minegishi Y et al. Acid suppression by proton pump inhibitors enhances aquaporin-4 and KCNQ1 expression in gastric fundic parietal cells in mouse. Dig. Dis. Sci. 2010; 55: 3339–48.
6. Naruki S, Fujino T, Ohnuma S, Endo A, Koizumi H. Histopathologic and immunohistochemical characterization of human gastric oxyntic mucosa with parietal cell protrusions and investigation into the association between such mucosal changes of the stomach and use of proton pump inhibitors. J. St. Marianna Univ. 2015; 6: 119–30.
7. Fujiya M, Sakatani A, Dokoshi T et al. A bamboo joint-like appearance is a characteristic finding in the upper gastrointestinal tract of Crohn's disease patients: a case-control study. Medicine (Baltimore) 2015; 94: e1500.
8. Hashiguchi K, Takeshima F, Akazawa Y et al. Bamboo joint-like appearance of the stomach: a stable endoscopic landmark for Crohn's disease regardless of anti-tumor necrosis factor alpha treatment. Med. Sci. Monit. 2014; 20: 1918–24.
9. Jin X, Koike T, Chiba T et al. Collagenous gastritis. Dig. Endosc. 2013; 25: 547–9.
10. Sugano K, Tack J, Kuipers EJ et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015; 64: 1353–67.